Phase I study to investigate the optimal dose and schedule of gemcitabine (G) and paclitaxel (P) in combination in patients with previously treated epithelial ovarian cancer. - Poole,C.J.; Perren,T.; Hogberg,T. (Proc Am Soc Clin Oncol, 1998)